Abstract
Abstract 1. Three patients with lymphosarcomatosis and two with disseminated Hodgkin’s disease were treated with massive doses (super-dosage) of nitrogen mustard (over 1.0 mg./Kg.) given intravenously, followed by the intravenous infusion of autologous bone marrow. 2. Two of the five patients succumbed to infection. The remaining three patients recovered within one month and experienced brief remissions. 3. It is suggested that this form of therapy merits further trial. Thus, it may be considered for use earlier in the course of the disease when there is a smaller total amount of tumor tissue, and thus a greater possibility for its complete eradication. Its use in other neoplastic disorders, as following operative procedures disclosing malignancy, is suggested.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
